Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Eight-Week, Multi-Site, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Trial to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Subjects With Rosacea Followed by an Open-Label Extension

NCT01740934 is registered in ClinicalTrials.gov with Rock Creek Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01740934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01740934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Eight-Week, Multi-Site, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Trial to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Subjects With Rosacea Followed by an Open-Label Extension
Lead sponsor
Rock Creek Pharmaceuticals, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2012
Completion date
August 31, 2013
Enrollment
117 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

rosacea